5HT2C CYS23/SER23 polymorphism is not associated with obsessive- compulsive disorder

Psychiatry Research

Volumn 77, Issue 2, 1998, Pages 97-104

  Cristina Cavallini, Maria ^a   Di Bella, Daniela ^a   Pasquale, Lorenza ^a   Henin, Marta ^a   Bellodi, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Challenge test; Clomipramine; Serotonergic receptors

Indexed keywords

CLOMIPRAMINE;

ADULT; ARTICLE; COMPULSION; DNA POLYMORPHISM; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; PRIORITY JOURNAL; PROVOCATION TEST; SEROTONINERGIC SYSTEM;

ADULT; ALLELES; CLOMIPRAMINE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; RNA, TRANSFER, CYS; RNA, TRANSFER, SER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0344653606     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)00151-0     Document Type: Article

References (34)

1. Altemus A., Murphy D.L., Greenberg B., Lesch K.P. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. American Journal of Medical Genetics (Neuropsychiatric Genetics). 67:1996;409-411.
2. American Psychiatric Association, 1987. DSMIII R: Diagnostic and Statistical Manual of Mental Disorders, 3rd rev. ed. American Psychiatric Press, Washington, DC.
3. Bastani B., Arora R.C., Meltzer H.Y. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive patients. Biological Psychiatry. 30(2):1991;131-139.
4. Bellodi L., Sciuto G., Diaferia G., Ronchi P., Smeraldi E. Psychiatric disorders in the families of patients with obsessive compulsive disorder. Psychiatry Research. 42:1992;111-120.
5. Benkelfat C., Murphy D.L., Zohar J., Hill J.L., Grover G., Insel T.R. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Archives of General Psychiatry. 46(1):1989;23-28.
6. Black D.W., Noyes R., Goldstein R.B., Blum N. A family study of obsessive-compulsive disorder. Archives of General Psychiatry. 49:1992;62-368.
7. Carey, G., Gottesman, I.I., 1981. Twin and family studies of anxiety, phobic and obsessive disorders. In: Klein, D.F., Rabkin, J. (Eds.), Anxiety: New Research and Changing Concepts. Raven Press, New York.
8. Di Bella D., Catalano M., Balling U., Smeraldi E., Lesch K. Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE. American Journal of Medical Genetics (Neuropsychiatric Genetics). 67:1996;541-545.
9. Dixon, W.J., Brown, M.B., Engelman L., Jenrich, R.I., 1990. BMDP: Statistical Software. University of California Press, Berkeley, Calif.
10. Dixon R.A.F., Sigal I.S., Candelore M.R., Register R.B., Scattergood W., Rands E., Strader C.D. Structural features required for ligand binding to the β-adrenergic receptor. EMBO Journal. 6:1987;3269-3275.
11. EPINFO version 6.02, 1994. A Word Processing, Database and Statistics Program for Public Health. Centers for Disease Control and Prevention (CDC), USA.
12. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleishmann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown obsessive compulsive scale, I: development, use and reliability. Archives of General Psychiatry. 46:1989;1006-1011.
13. Hanna G.L., Yuwiler A., Cantwell D.P. Whole blood serotonin in juvenile obsessive-compulsive disorder. Biological Psychiatry. 29(8):1991;738-744.
14. Hollander E., De Caria C.M., Nitescu A., Gully R., Sukow R.F., Cooper T.B., Gorman J.M., Klein D.F., Liebowitz M.R. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine response to oral m-clorophenilpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry. 49:1992;21-28.
15. Insel T.R., Mueller E.A., Alterman I., Linnoila M., Murphy D.L. Obsessive-compulsive disorder and serotonin: is there a connection? Biological Psychiatry. 20(11):1985;1174-1188.
16. Jenike M.A., Hyman S.E., Baer L., Holland A., Minichiello W.E., Buttolph L., Summergrad P., Seymour R., Ricciardi J. A controlled trial of fluvoxamine for obsessive compulsive disorder: implications for a serotonergic theory. American Journal of Psychiatry. 147:1990;1209-1215.
17. 3H-imipramine binding sites in obsessive-compulsive behavior. Biological Psychiatry. 30(5):1991;467-474.
18. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Research. 19(19):1991;5444.
19. 23 substitution in the human 5-HT2C receptor gene (5HTR2C). Genomics. 27:1995;274-279.
20. Leckman J.F., Goodman W.K., Riddle M.A., Hardin M.T., Anderson G.M. Low CSF 5HIAA and obsessions of violence: report of two cases. Psychiatry Research. 35:1990;95-99.
21. Leckman J.F., Goodman W.K., Anderson G.M., Riddle M.A., Chappell P.B., McSwiggan-Hardin M.J., McDougle C.J., Scahill L.D., Ort S.I., Pauls D.L. Cerebrospinal fluid biogenic amines in obsessive-compulsive disorders Tourette's syndrome and healthy controls. Neuropsychopharmacology. 12(1):1995;73-86.
22. Leonard H.L., Swedo S.E., Rapoport J.L., Coffey M., Cheslow D. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents: a double blind cross-over comparison. Archives of General Psychiatry. 46:1989;1088-1092.
23. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorders. A double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry. 51(4):1994;302-308.
24. Mundo E., Bellodi L., Smeraldi E. Effects of the acute intravenous clomipramine on obsessive-compulsive symptoms and response to chronic treatment. Biological Psychiatry. 38(8):1995;525-531.
25. Nicolini H., Hanna G., Baxter L., Schwartz J., Weissbacker K., Spence M.A. Segregation analysis of obsessive compulsive disorders: preliminary results. Ursus Medicus. 1:1991;25-28.
26. Nicolini H., Cruz C., Camarena B., Orozco B., Kennedy J.L., King N., Weissbacker K., De La Fuente J.R., Sidenberg D. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Molecular Psychiatry. 1(6):1996;461-465.
27. Pauls D.L., Alsobrook I.I., Goodman W., Rasmussen S., Leckman J.F. A family study of obsessive-compulsive disorder. American Journal of Psychiatry. 152:1995;76-84.
28. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21(1):1987;123-139.
29. Rapoport J. Obsessive compulsive disorder and basal ganglia dysfunction. Psychological Medicine. 20:1990;465-469.
30. Rauch S.L., Jenike M.A. Neurobiological models of obsessive-compulsive disorder. Psychosomatics. 34:1993;2032.
31. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
32. Robins L.N., Helzer T.E., Croughan J., Ratcliff K.S. The National Institute of Mental Health diagnostic interview schedule: its history, characteristics and validity. Archives of General Psychiatry. 38:1981;381-389.
33. Strosberg A.D. Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. European Journal of Biochemistry. 196:1991;1-10.
34. Zohar J., Mueller E.A., Insel T.R., Zohar-Kadouch R.C., Murphy D.L. Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Archives of General Psychiatry. 44:1987;946-951.